(Q54117515)

25 May 2018

title

Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty. (English)

1 reference

25 May 2018

1 reference

1 reference

1 reference

J A Bittl

1

1 reference

25 May 2018

W H Ahmed

series ordinal

2

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 May 2018

American Journal of Cardiology

published in

1 reference

25 May 2018

volume

82

1 reference

25 May 2018

issue

8B

1 reference

25 May 2018

page(s)

50P-56P

1 reference

25 May 2018

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Length of hospital stay and complications after percutaneous transluminal coronary angioplasty. Clinical and procedural predictors. Heparin Registry Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Relation between activated clotting time during angioplasty and abrupt closure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Is aggressive heparinization necessary for elective PTCA?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

The prognostic importance of the electrocardiogram after myocardial infarction. Experience in the Coronary Drug Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Tran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900760-7

10.1016/S0002-9149(98)00760-7

7 January 2021

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018